Gene · 23643
Papers4,579
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 4,579
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Roles of Toll-Like Receptors in Radiotherapy- and Chemotherapy-Induced Oral Mucositis: A Concise Review. | Front Cell Infect Microbiol | 2022 | 35719331 | PubTator, text mining | PubMed |
| Identifying crucial biomarkers in peripheral blood of schizophrenia and screening therapeutic agents by comprehensive bioinformatics analysis. | J Psychiatr Res | 2022 | 35716513 | PubTator, text mining | PubMed |
| Pathophysiological Significance of GM3 Ganglioside Molecular Species With a Particular Attention to the Metabolic Syndrome Focusing on Toll-Like Receptor 4 Binding. | Front Mol Biosci | 2022 | 35712350 | PubTator, text mining | PubMed |
| Can natural products modulate cytokine storm in SARS-CoV2 patients? | Biotechnol Rep (Amst) | 2022 | 35702395 | PubTator, text mining | PubMed |
| RP105 protects against ischemic and septic acute kidney injury via suppressing TLR4/NF-κB signaling pathways. | Int Immunopharmacol | 2022 | 35696803 | PubTator, text mining | PubMed |
| Pyroptosis and Its Role in Autoimmune Disease: A Potential Therapeutic Target. | Front Immunol | 2022 | 35693810 | PubTator, text mining | PubMed |
| Identification of Immune-Related Genes in Patients with Acute Myocardial Infarction Using Machine Learning Methods. | J Inflamm Res | 2022 | 35692951 | PubTator, text mining | PubMed |
| Exploring biomarkers for ischemic stroke through integrated microarray data analysis. | Brain Res | 2022 | 35691413 | PubTator, text mining | PubMed |
| Fibronectin containing alternatively spliced extra domain A interacts at the central and c-terminal domain of Toll-like receptor-4. | Sci Rep | 2022 | 35690624 | PubTator, text mining | PubMed |
| Effects of Linkers and Substitutions on Multitarget Directed Ligands for Alzheimer's Diseases: Emerging Paradigms and Strategies. | Int J Mol Sci | 2022 | 35682763 | PubTator, text mining | PubMed |
| Could a Lower Toll-like Receptor (TLR) and NF-κB Activation Due to a Changed Charge Distribution in the Spike Protein Be the Reason for the Lower Pathogenicity of Omicron? | Int J Mol Sci | 2022 | 35682644 | PubTator, text mining | PubMed |
| Signaling pathways of chronic kidney diseases, implications for therapeutics. | Signal Transduct Target Ther | 2022 | 35680856 | PubTator, text mining | PubMed |
| The role of Toll-like receptors and neuroinflammation in Parkinson's disease. | J Neuroinflammation | 2022 | 35668422 | PubTator, text mining | PubMed |
| Melatonin and multiple sclerosis: antioxidant, anti-inflammatory and immunomodulator mechanism of action. | Inflammopharmacology | 2022 | 35665873 | PubTator, text mining | PubMed |
| A Candidate Drug Screen Strategy: The Discovery of Oroxylin A in Scutellariae Radix Against Sepsis via the Correlation Analysis Between Plant Metabolomics and Pharmacodynamics. | Front Pharmacol | 2022 | 35662699 | PubTator, text mining | PubMed |
| Interplay of retinol binding protein 4 with obesity and associated chronic alterations (Review). | Mol Med Rep | 2022 | 35656886 | PubTator, text mining | PubMed |
| Neuroprotective Effects of Celastrol in Neurodegenerative Diseases-Unscramble Its Major Mechanisms of Action and Targets. | Aging Dis | 2022 | 35656110 | PubTator, text mining | PubMed |
| Low-dose melittin is safe for intravitreal administration and ameliorates inflammation in an experimental model of uveitis. | Curr Res Pharmacol Drug Discov | 2022 | 35647524 | PubTator, text mining | PubMed |
| Pan-Cancer Analysis of the Characteristics of LY96 in Prognosis and Immunotherapy Across Human Cancer. | Front Mol Biosci | 2022 | 35647025 | PubTator, text mining | PubMed |
| Morphine-3-Glucuronide, Physiology and Behavior. | Front Mol Neurosci | 2022 | 35645730 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23643/papers?page=47